The Bipartisan Policy Center this week kicked off its five-point “FDA: Advancing Medical Innovation” initiative, with the first session addressing how to accelerate the discovery, development and delivery of medical products.
The Bipartisan Policy Center this week kicked off its five-point “FDA: Advancing Medical Innovation” initiative, with the first session addressing how to accelerate the discovery, development and delivery of medical products.